Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate
Author:
Affiliation:
1. Department of Animal Medicine and Surgery, School of Veterinary Medicine Complutense University of Madrid Madrid Spain
Funder
Universidad Complutense de Madrid
Publisher
Wiley
Subject
General Veterinary
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/vco.12760
Reference47 articles.
1. Inflammatory mammary carcinoma in the dog;Susaneck SJ;J Am Anim Hosp Assoc,1983
2. Inflammatory mammary carcinoma in dogs: 33 cases (1995‐1999);Perez Alenza MD;J Am Vet Med Assoc,2001
3. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003‐2008);Marconato L;J Am Vet Med Assoc,2009
4. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase‐2 expression, and response to piroxicam treatment;M Souza CH;Can Vet J,2009
5. Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases;Pena L;Breast Cancer Res Treat,2003
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intensive Multimodal Chemotherapy in a Dog Suffering from Grade III/Stage IV Solid Mammary Carcinoma;Animals;2024-09-09
2. Cytological Features of Inflammatory Mammary Carcinoma in Dogs;Veterinary Sciences;2024-08-23
3. Metronomic chemotherapy: bridging theory to clinical application in canine and feline oncology;Frontiers in Veterinary Science;2024-06-06
4. Halofuginone-guided nano-local therapy: Nano-thermosensitive hydrogels for postoperative metastatic canine mammary carcinoma with scar removal;International Journal of Pharmaceutics: X;2024-06
5. Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours;Veterinary and Comparative Oncology;2024-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3